nicotine has been researched along with Neurodegenerative Diseases in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (71.43) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L; Kuang, H; Li, X; Liu, L; Xu, C; Xu, L | 1 |
| Farokhi, N; Motaghinejad, M; Motevalian, M; Safari, S | 1 |
| Alcaraz-Silva, J; Barberena, JJ; Budde, H; Imperatori, C; Machado, S; Murillo-Rodríguez, E; Quiroga, C; Telles-Correia, D; Yadollahpour, A; Yamamoto, T | 1 |
| Chaudhary, A; Choudhary, P; Gupta, A; Pahal, S; Singh, S | 1 |
| Corsini, S; Nistri, A; Tortora, M | 1 |
| Miyata, H | 1 |
| Shimohama, S | 1 |
| Bertrand, D; D'hoedt, D | 1 |
| Campagnolo, D; Dayao, C; Lukas, RJ; Piao, WH; Shi, FD; Wu, J | 1 |
| Cappendijk, SL; Chalise, P; Halquist, MS; James, JR; Miller, GL; Pirvan, DF; Rodriguez, MI | 1 |
| Arendash, GW; Bickford, PC; Newman, MB; Sanberg, PR; Shytle, RD; Tighe, T | 1 |
| Ando, K | 1 |
| Bridge, MH; Linert, W; Lyons, ME; Tipton, KF; Williams, E | 1 |
| Carrasco, C; Redolat, R; Vicens, P | 1 |
| Celuch, M; Danilczuk, M; Pogocki, D; Ruman, T; Wałajtys-Rode, E | 1 |
| Picciotto, MR; Zoli, M | 1 |
| Ballard, CG; Cookson, N; Court, JA; Lloyd, S; McKeith, IG; Perry, EK; Perry, RH; Piggott, MA | 1 |
| Kimes, AS; Koren, AO; Långström, B; London, ED; Mukhin, AG; Nordberg, A; Sihver, W | 1 |
| Kawakami, H; Nakamura, S; Takahashi, T; Yamashita, H | 1 |
| Biagini, G; Leo, G; Zanardi, A; Zoli, M | 1 |
13 review(s) available for nicotine and Neurodegenerative Diseases
| Article | Year |
|---|---|
The Role of Peroxisome Proliferator-Activated Receptor in Addiction: A Novel Drug Target.
Topics: Alcohols; Analgesics, Opioid; Behavior, Addictive; Cannabis; Cocaine; Humans; Ligands; Methamphetamine; Molecular Targeted Therapy; Neurodegenerative Diseases; Nicotine; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptors; Pharmaceutical Preparations; Protein Isoforms; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2021 |
[Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
Topics: Drug Design; Humans; Mental Disorders; Neurodegenerative Diseases; Nicotine; Nicotinic Agonists; Protein Subunits; Receptors, Nicotinic; Smoking | 2008 |
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Animals; Drug Synergism; Galantamine; Glutamic Acid; Motor Neurons; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinson Disease, Secondary; Phosphatidylinositol 3-Kinases; Rats; Receptors, Nicotinic; Rotenone; Signal Transduction; Spinal Cord | 2009 |
Nicotinic acetylcholine receptors: an overview on drug discovery.
Topics: Allosteric Regulation; Analgesics; Bridged Bicyclo Compounds, Heterocyclic; Cardiovascular Diseases; Drug Discovery; Hearing; Humans; Myasthenia Gravis; Neurodegenerative Diseases; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pain; Protein Subunits; Psoriasis; Pyridines; Receptors, Nicotinic; Schizophrenia; Smoking; Smoking Cessation; Tobacco Use Disorder | 2009 |
Nicotine and inflammatory neurological disorders.
Topics: Animals; Humans; Immune System; Inflammation; Neurodegenerative Diseases; Nicotine; Nicotinic Agonists; Smoking | 2009 |
Nicotine's oxidative and antioxidant properties in CNS.
Topics: Animals; Antioxidants; Cells, Cultured; Central Nervous System; Free Radical Scavengers; Humans; Iron; Neurodegenerative Diseases; Nicotine; Oxidative Stress; Rats; Reactive Oxygen Species; Receptors, Nicotinic | 2002 |
[Neuropsychopharmacological profile of nicotine].
Topics: Animals; Behavior, Addictive; Drug Design; Humans; Injections, Intravenous; Limbic System; Neurodegenerative Diseases; Nicotine; Nicotinic Agonists; Psychotropic Drugs; Receptors, Nicotinic; Reinforcement, Psychology; Self Administration; Smoking | 2004 |
Neuroprotective effects of behavioural training and nicotine on age-related deficits in spatial learning.
Topics: Aging; Animals; Behavior Therapy; Escape Reaction; Hippocampus; Humans; Maze Learning; Mental Recall; Neurodegenerative Diseases; Neuroprotective Agents; Nicotine; Orientation; Practice, Psychological; Problem Solving; Rats; Receptors, Nicotinic; Septum Pellucidum | 2006 |
Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders.
Topics: Animals; Drugs, Investigational; Humans; Isomerism; Neurodegenerative Diseases; Nicotiana; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Technology, Pharmaceutical | 2007 |
Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease.
Topics: Alzheimer Disease; Animals; Binding Sites; Brain; Humans; Models, Biological; Neurodegenerative Diseases; Neuroprotective Agents; Nicotine; Parkinson Disease; Receptors, Nicotinic; Signal Transduction | 2008 |
Development of ligands for in vivo imaging of cerebral nicotinic receptors.
Topics: Animals; Brain; Brain Mapping; Humans; Neurodegenerative Diseases; Nicotine; Receptors, Nicotinic; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Nicotinic acetylcholine receptors and neurodegenerative disease.
Topics: Animals; Humans; Neurodegenerative Diseases; Nicotine; Receptors, Nicotinic | 2001 |
Nicotine and neurodegeneration in ageing.
Topics: Age Factors; Aging; Amyloid beta-Protein Precursor; Animals; Cognition; Cognition Disorders; Humans; Nervous System; Neurodegenerative Diseases; Nicotine; Receptors, Nicotinic | 2002 |
8 other study(ies) available for nicotine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Development of a colloidal gold immunochromatographic strip for rapid and sensitive detection of nicotine.
Topics: Antibodies, Monoclonal; Chromatography, Affinity; Electronic Nicotine Delivery Systems; Gold Colloid; Humans; Limit of Detection; Neurodegenerative Diseases; Nicotine; Oils; Reproducibility of Results | 2023 |
Molecular, histological and behavioral evidences for neuroprotective effects of minocycline against nicotine-induced neurodegeneration and cognition impairment: Possible role of CREB-BDNF signaling pathway.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cognition; Cognitive Dysfunction; Cyclic AMP Response Element-Binding Protein; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Hippocampus; Lipid Peroxidation; Male; Minocycline; Neurodegenerative Diseases; Neuroprotection; Neuroprotective Agents; Nicotine; Oxidative Stress; Rats; Rats, Wistar; Signal Transduction; Superoxide Dismutase | 2020 |
Network pharmacological evaluation of
Topics: Alzheimer Disease; Humans; Molecular Docking Simulation; Neurodegenerative Diseases; Nicotine; Phytochemicals; Plant Extracts; Withania | 2022 |
Nicotinic receptor activation contrasts pathophysiological bursting and neurodegeneration evoked by glutamate uptake block on rat hypoglossal motoneurons.
Topics: Action Potentials; Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Brain Stem; Endoplasmic Reticulum Stress; Glucosyltransferases; Glutamic Acid; Hypoglossal Nerve; Motor Neurons; Neurodegenerative Diseases; Nicotine; Nicotinic Antagonists; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Nicotinic | 2016 |
In vivo nicotine exposure in the zebra finch: a promising innovative animal model to use in neurodegenerative disorders related research.
Topics: Animals; Body Weight; Chromatography, Liquid; Cotinine; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Feces; Finches; Male; Motor Activity; Neurodegenerative Diseases; Nicotine; Songbirds; Tandem Mass Spectrometry; Vocalization, Animal | 2010 |
Electrochemical investigation into the redox activity of Fe(II)/Fe(III) in the presence of nicotine and possible relations to neurodegenerative diseases.
Topics: Electrochemistry; Electron Transport; Ferric Compounds; Ferrous Compounds; Humans; Hydrogen-Ion Concentration; Iron; Neurodegenerative Diseases; Nicotine; Oxidation-Reduction | 2004 |
[Contents of the short news].
Topics: Animals; Biomedical Research; Drosophila; Ganglionic Stimulants; Genetics; Humans; Hypotension; Kidney; Neurodegenerative Diseases; Neurophysiology; Nicotine; Obesity; Poverty; Tumor Suppressor Protein p53 | 2005 |
Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Cognition Disorders; Female; Humans; Lewy Body Disease; Male; Middle Aged; Neostriatum; Neurodegenerative Diseases; Nicotiana; Nicotine; Parkinson Disease; Plants, Toxic; Radioligand Assay; Receptors, Dopamine D2; Receptors, Nicotinic; Schizophrenia; Sex Factors; Synapses; Tritium | 2000 |